These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man. Kesäniemi YA; Grundy SM JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883 [TBL] [Abstract][Full Text] [Related]
30. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy. Falko JM; Witztum JL; Schonfeld G; Weidman SW; Kolar JB Am J Med; 1979 Feb; 66(2):303-10. PubMed ID: 218451 [No Abstract] [Full Text] [Related]
31. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)]. Weisweiler P; Schwandt P Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601 [TBL] [Abstract][Full Text] [Related]
32. The use of nitroblue tetrazolium prestaining of serum lipoproteins on polyacrylamide disc electrophoresis. Segal AW; Putman D; Levi AJ; Lewis B Clin Chim Acta; 1974 Jun; 53(3):361-7. PubMed ID: 4367870 [No Abstract] [Full Text] [Related]
33. Change of lipoprotein pattern by clofibrate in hyperglyceridaemia and mixed hyperlipidaemia. Miettinen TA; Penttilä IM; Lampainen E Acta Med Scand; 1972 Sep; 192(3):177-82. PubMed ID: 4341290 [No Abstract] [Full Text] [Related]
35. Classifications of the hyperlipidemias. Havel RJ Annu Rev Med; 1977; 28():195-209. PubMed ID: 193431 [No Abstract] [Full Text] [Related]
36. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate]. Gaertner U; Johannes KJ MMW Munch Med Wochenschr; 1976 Sep; 118(36):1127-30. PubMed ID: 184377 [TBL] [Abstract][Full Text] [Related]
37. A case of massive hypertriglyceridemia corrected by nicotinic acid or nicotinamide therapy. Carlson LA; Fröberg S; Orö L Atherosclerosis; 1972; 16(3):359-68. PubMed ID: 4348602 [No Abstract] [Full Text] [Related]
38. Transport kinetics of plasma free fatty acid, very low density lipoprotein triglycerides and apoprotein in patients with endogenous hypertriglyceridaemia: effects of 2,2-dimethyl, 5(2, 5-xylyoxy) valeric acid therapy. Kissebah AH; Alfarsi S; Adams PW; Seed M; Folkard J; Wynn V Atherosclerosis; 1976; 24(1-2):199-218. PubMed ID: 182185 [TBL] [Abstract][Full Text] [Related]
39. The primary hyperlipoproteinemias. Bybee DE; Hamilton RD J Ky Med Assoc; 1974 Dec; 72(12):658-62. PubMed ID: 4373515 [No Abstract] [Full Text] [Related]
40. Diet and drug treatment of hyperlipidemia and atherosclerosis. Kuo PT Ann Clin Lab Sci (1971); 1972; 2(4):322-4. PubMed ID: 4342101 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]